Design, analyse, interpret and report clinical research and clinical trials.
Working at postgraduate level, apprentices develop the scientific and regulatory expertise needed to design, analyse, interpret, and report clinical research and clinical trials. This spans study design methodology, statistical analysis of clinical data, pharmacokinetics, pharmacodynamics, and the regulatory frameworks governing drug development. Apprentices also build skills in critically appraising evidence, writing scientific reports, and applying Good Clinical Practice (GCP) standards to real-world research programmes.
Week to week, apprentices work alongside experienced clinical pharmacologists and medical scientists on live trials or research projects. Typical tasks include reviewing and analysing clinical datasets, drafting sections of clinical study reports, contributing to protocol development, and liaising with regulatory affairs teams. They may use statistical software such as SAS or R, maintain trial documentation in line with GCP requirements, and attend multidisciplinary project meetings where data interpretation informs decision-making.
Completing this degree-level apprenticeship typically leads to roles such as Clinical Pharmacologist, Clinical Scientist, Pharmacokinetics Scientist, or Clinical Research Scientist. Progression can move toward senior or principal scientist positions, and some go on to regulatory affairs or medical affairs roles. The main employers are pharmaceutical and biopharmaceutical companies, contract research organisations (CROs), NHS Trusts, and government bodies such as the MHRA. The integrated degree qualification supports registration pathways and carries weight across both industry and academic research settings.
Sorted by achievement rate.
No training providers currently listed for this standard.
Graduates typically move into Clinical Pharmacologist, Clinical Research Scientist, or Pharmacokinetics Scientist positions within drug development teams. Some take on Clinical Trials Analyst or Regulatory Affairs Scientist roles, applying their statistical and pharmacological expertise to submissions for medicines licensing. A smaller number move directly into Medical Affairs Scientist posts, acting as a scientific bridge between clinical data and commercial or medical functions within a pharmaceutical organisation.
Within three to five years, many progress to Senior Clinical Pharmacologist or Principal Clinical Research Scientist, taking responsibility for study design and cross-functional oversight of trials. The leadership track typically leads toward Clinical Pharmacology Lead or Head of Clinical Development. The specialist track runs toward expert positions in pharmacokinetics/pharmacodynamics modelling, translational science, or regulatory strategy, with Consulting Principal Scientist and Distinguished Scientist grades at the senior end of large pharmaceutical organisations.
The primary employers are pharmaceutical and biopharmaceutical companies, contract research organisations, and contract development and manufacturing organisations operating across the UK and internationally. NHS clinical research facilities and academic medical centres also hire at this level, often in joint posts with universities. Medicines and Healthcare products Regulatory Agency (MHRA) positions draw on the same skill set. Most roles sit in private-sector drug development, though public and academic settings offer a meaningful alternative pathway.
Throughout the programme, apprentices build competence in designing, analysing, interpreting and reporting clinical research and clinical trials while working in their employing organisation. Assessment is integrated into the programme rather than front-loaded at one point, with evidence of knowledge, skills and behaviours gathered progressively in a genuine clinical research setting. Before final assessment can take place, the apprentice and employer confirm through a readiness check, commonly called a gateway, that the required level of competence has been demonstrated. The assessment model for many Level 7 standards is currently being updated, so check the standard's gov.uk page for the current specification.
Apprentices at this level are working with complex, real-world clinical data and trial processes from early in the programme, so keeping detailed, dated records of that work is important from the start. A portfolio of workplace evidence, built steadily rather than assembled in a rush near the end, gives a much clearer picture of genuine competence. Regular review points with both the employer and training provider help identify gaps early and ensure readiness before the gateway. Candidates should also stay familiar with relevant regulatory frameworks and reporting standards, as these form a core part of what competence looks like in this role.
Look for providers with an achievement rate above 75% on their FATP profile; at Level 7 with a 30-month programme, a lower rate may indicate poor learner support or mismatched entry requirements. Employer satisfaction scores above 80% matter here because the work is highly regulated, and close collaboration between provider and employer on trial design and data interpretation is non-negotiable. Check that teaching staff hold current research credentials and that learners get exposure to live or realistic clinical trial environments, not just classroom theory. Apprentice satisfaction reviews mentioning real study design work are a positive signal.
Be cautious of providers with high apprentice volumes but falling achievement rates, which at this level may reflect overstretched academic supervision. If a provider is vague about how they integrate GCP (Good Clinical Practice) training or cannot confirm that learners work on actual trial data or validated simulation environments, that is a concern. Providers who cannot show where recent graduates are working, whether in pharma, CROs, or NHS research settings, should be pressed hard for evidence. Opaque answers about cohort sizes at this specialist level are worth probing.
Applicants typically need a relevant undergraduate degree in a life science, pharmacy, or related discipline. Employers will set their own entry criteria, but a strong grounding in biology, chemistry, or pharmacology is usually expected. Some employers may also look for prior experience in a clinical or research setting. The apprentice must be in paid employment throughout and the role must require the skills and knowledge covered by the standard.
The typical duration is 30 months, though this can vary depending on prior learning and the employer's programme structure. The apprentice remains employed throughout, applying learning directly to their work in clinical research or trials. A portion of working time must be dedicated to off-the-job learning, but the exact requirement is subject to current Skills England reforms. Check the current specification on gov.uk for the latest figure.
Before reaching the end-point assessment, the apprentice must pass through a gateway, where the employer and training provider confirm the apprentice has met the required standard of competence. Assessment methods for many Level 7 standards are being reviewed as part of ongoing reforms, so the specific assessment components may change. The current end-point assessment details are published on the Institute for Apprenticeships and Technical Education page for this standard on gov.uk.
The funding band for this standard is £18,000, which is the maximum that can be drawn from the apprenticeship levy or claimed through government co-investment. Large employers with an apprenticeship levy account use those funds directly. Smaller employers typically contribute 5% of the training cost, with the government covering the rest. Employers with fewer than 50 staff taking on an apprentice aged 16 to 18 pay nothing. Actual provider fees are agreed separately and may be at or below the funding band.
Day-to-day work centres on supporting or leading clinical research activity. That includes designing clinical trials, writing and reviewing protocols, analysing pharmacological data, and interpreting results to produce written reports. The apprentice may also liaise with regulatory bodies, apply statistical methods to trial data, and contribute to safety monitoring. The specific tasks depend on the employer, who might be a pharmaceutical company, contract research organisation, NHS trust, or academic research institution.
Completing this apprenticeship leads to a Master's level qualification in clinical pharmacology. From there, career progression typically moves towards senior scientist, principal scientist, or clinical pharmacology lead roles. Some graduates pursue registration as a clinical scientist with the Health and Care Professions Council, depending on their route. Others move into regulatory affairs, medical affairs, or broader drug development functions. The qualification is also a strong foundation for doctoral research in pharmacology or related disciplines.
Tell us a bit about your team and we'll send a shortlist.
Tell us your requirements and we'll match you with the right training providers.
Curated by Alex Lockey, FATP founder and editor. Last reviewed: .
Sources include the apprenticeship's official specification on apprenticeships.gov.uk, Skills England guidance, IfATE archive records, DWP funding bands, and provider data sourced directly from the public Apprenticeship Provider and Assessment Register (APAR). Standard reference: 604.
Some sections on this page were drafted with AI assistance from published source data and reviewed by a human editor before publication. See our editorial methodology for how we maintain this content. Spotted something out of date? Tell us.